LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Ihre letzten Suchen

  1. AU="Petrina Jáuregui, Estrella"
  2. AU="Chiang, Angela"
  3. AU="Balvert, Willemien"
  4. AU="Matic, Nancy"
  5. AU="Cerqueira, Rui"
  6. AU="Greco, Massimiliano"
  7. AU="Dalton, Michelle"
  8. AU="Letard, Sébastien"
  9. AU="Di Gangi, Iole Maria"
  10. AU="Chen, T T"
  11. AU="Alves, Luiz Felipe M F"
  12. AU="Liao, Jing" AU="Liao, Jing"

Suchergebnis

Treffer 1 - 7 von insgesamt 7

Suchoptionen

  1. Artikel ; Online: Impact of bariatric surgery on bone tissue.

    Botella Martínez, Sonsoles / Petrina Jauregui, Estrella / Escalada San Martín, Javier

    Endocrinologia, diabetes y nutricion

    2018  Band 66, Heft 1, Seite(n) 62–68

    Abstract: The important prevalence and morbidity of obesity has generated an increase in bariatric surgery. It has a positive effect in obesity-related comorbidities. However, it's detrimental to bone health. The underline pathophysiological mechanisms are complex ...

    Titelübersetzung Impacto de la cirugía bariátrica en el tejido óseo.
    Abstract The important prevalence and morbidity of obesity has generated an increase in bariatric surgery. It has a positive effect in obesity-related comorbidities. However, it's detrimental to bone health. The underline pathophysiological mechanisms are complex and heterogeneous. The knowledge of these factors may lead us to develop an adequate therapeutic intervention.
    Mesh-Begriff(e) Bariatric Surgery/adverse effects ; Bone Diseases/etiology ; Bone Diseases/physiopathology ; Bone Diseases/therapy ; Humans ; Postoperative Complications/etiology ; Postoperative Complications/physiopathology ; Postoperative Complications/therapy
    Sprache Spanisch
    Erscheinungsdatum 2018-09-25
    Erscheinungsland Spain
    Dokumenttyp Journal Article ; Review
    ISSN 2530-0180
    ISSN (online) 2530-0180
    DOI 10.1016/j.endinu.2018.06.009
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  2. Artikel ; Online: Diet low in fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAPs) in the treatment of irritable bowel syndrome: indications and design.

    Zugasti Murillo, Ana / Estremera Arévalo, Fermín / Petrina Jáuregui, Estrella

    Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion

    2016  Band 63, Heft 3, Seite(n) 132–138

    Abstract: In recent years, there has been growing interest in diet low in FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides and polyols) as an important mainstay in the treatment of irritable bowel syndrome (IBS). This model of diet was ... ...

    Abstract In recent years, there has been growing interest in diet low in FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides and polyols) as an important mainstay in the treatment of irritable bowel syndrome (IBS). This model of diet was developed by a multidisciplinary team from the Monash University in Melbourne and became well-known after the publication of a study in 2008 showing that dietary FODMAPs acted as causing factors in patients with IBS. Since then there have been several randomized controlled trials which, although with small sample sizes, have again shown the benefits of this dietary pattern.
    Mesh-Begriff(e) Diet ; Disaccharides ; Fermentation ; Humans ; Irritable Bowel Syndrome/diet therapy ; Monosaccharides ; Oligosaccharides
    Chemische Substanzen Disaccharides ; Monosaccharides ; Oligosaccharides
    Sprache Spanisch
    Erscheinungsdatum 2016-03
    Erscheinungsland Spain
    Dokumenttyp Journal Article
    ZDB-ID 1469349-5
    ISSN 1579-2021 ; 0211-2299 ; 1575-0922
    ISSN (online) 1579-2021
    ISSN 0211-2299 ; 1575-0922
    DOI 10.1016/j.endonu.2015.10.009
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  3. Artikel ; Online: Parenteral nutrition-associated liver disease and lipid emulsions.

    Zugasti Murillo, Ana / Petrina Jáuregui, Estrella / Elizondo Armendáriz, Javier

    Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion

    2015  Band 62, Heft 6, Seite(n) 285–289

    Abstract: Parenteral nutrition-associated liver disease (PNALD) is a particularly important problem in patients who need this type of nutritional support for a long time. Prevalence of the condition is highly variable depending on the series, and its clinical ... ...

    Abstract Parenteral nutrition-associated liver disease (PNALD) is a particularly important problem in patients who need this type of nutritional support for a long time. Prevalence of the condition is highly variable depending on the series, and its clinical presentation is different in adults and children. The etiology of PNALD is not well defined, and participation of several factors at the same time has been suggested. When a bilirubin level >2 mg/dl is detected for a long time, other causes of liver disease should be ruled out and risk factors should be minimized. The composition of lipid emulsions used in parenteral nutrition is one of the factors related to PNALD. This article reviews the different types of lipid emulsions and the potential benefits of emulsions enriched with omega-3 fatty acids.
    Mesh-Begriff(e) Fat Emulsions, Intravenous/adverse effects ; Fat Emulsions, Intravenous/classification ; Humans ; Liver Diseases/etiology ; Parenteral Nutrition/adverse effects
    Chemische Substanzen Fat Emulsions, Intravenous
    Sprache Spanisch
    Erscheinungsdatum 2015-06
    Erscheinungsland Spain
    Dokumenttyp Journal Article ; Review
    ZDB-ID 1469349-5
    ISSN 1579-2021 ; 0211-2299 ; 1575-0922
    ISSN (online) 1579-2021
    ISSN 0211-2299 ; 1575-0922
    DOI 10.1016/j.endonu.2015.03.008
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  4. Artikel ; Online: Emulsión lipídica exclusiva de ácidos grasos omega-3 (Omegaven®) en el tratamiento de la hepatopatía asociada a nutrición parenteral: a propósito de un caso.

    Zugasti Murillo, Ana / Petrina Jáuregui, Estrella / Elizondo Armendáriz, Javier

    Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion

    2015  Band 62, Heft 6, Seite(n) 294–296

    Titelübersetzung Exclusively based parenteral fish-oil emulsion (Omegaven®) in the treatment of parenteral nutrition associated liver disease: Report of a case.
    Mesh-Begriff(e) Adult ; Female ; Fish Oils/administration & dosage ; Humans ; Liver Diseases/etiology ; Liver Diseases/therapy ; Parenteral Nutrition/adverse effects
    Chemische Substanzen Fish Oils ; Omegaven (XGF7L72M0F)
    Sprache Spanisch
    Erscheinungsdatum 2015-04-17
    Erscheinungsland Spain
    Dokumenttyp Case Reports ; Letter
    ZDB-ID 1469349-5
    ISSN 1579-2021 ; 0211-2299 ; 1575-0922
    ISSN (online) 1579-2021
    ISSN 0211-2299 ; 1575-0922
    DOI 10.1016/j.endonu.2015.03.002
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  5. Artikel ; Online: Farmacobezoar por nutrición enteral.

    Toni García, Marta / Zugasti Murillo, Ana / Pueyo Royo, Antonio / Petrina Jáuregui, Estrella

    Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion

    2011  Band 58, Heft 5, Seite(n) 249–251

    Titelübersetzung Pharmacobezoar induced by enteral nutrition.
    Mesh-Begriff(e) Bezoars/etiology ; Enteral Nutrition/adverse effects ; Humans ; Male ; Middle Aged
    Sprache Spanisch
    Erscheinungsdatum 2011-05
    Erscheinungsland Spain
    Dokumenttyp Case Reports ; Letter
    ZDB-ID 1469349-5
    ISSN 1579-2021 ; 0211-2299 ; 1575-0922
    ISSN (online) 1579-2021
    ISSN 0211-2299 ; 1575-0922
    DOI 10.1016/j.endonu.2010.12.006
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  6. Artikel: Transferrin Isoforms, Old but New Biomarkers in Hereditary Fructose Intolerance.

    Cano, Ainara / Alcalde, Carlos / Belanger-Quintana, Amaya / Cañedo-Villarroya, Elvira / Ceberio, Leticia / Chumillas-Calzada, Silvia / Correcher, Patricia / Couce, María Luz / García-Arenas, Dolores / Gómez, Igor / Hernández, Tomás / Izquierdo-García, Elsa / Martínez Chicano, Dámaris / Morales, Montserrat / Pedrón-Giner, Consuelo / Petrina Jáuregui, Estrella / Peña-Quintana, Luis / Sánchez-Pintos, Paula / Serrano-Nieto, Juliana /
    Unceta Suarez, María / Vitoria Miñana, Isidro / de Las Heras, Javier

    Journal of clinical medicine

    2021  Band 10, Heft 13

    Abstract: Hereditary Fructose Intolerance (HFI) is an autosomal recessive inborn error of metabolism characterised by the deficiency of the hepatic enzyme aldolase B. Its treatment consists in adopting a fructose-, sucrose-, and sorbitol (FSS)-restrictive diet for ...

    Abstract Hereditary Fructose Intolerance (HFI) is an autosomal recessive inborn error of metabolism characterised by the deficiency of the hepatic enzyme aldolase B. Its treatment consists in adopting a fructose-, sucrose-, and sorbitol (FSS)-restrictive diet for life. Untreated HFI patients present an abnormal transferrin (Tf) glycosylation pattern due to the inhibition of mannose-6-phosphate isomerase by fructose-1-phosphate. Hence, elevated serum carbohydrate-deficient Tf (CDT) may allow the prompt detection of HFI. The CDT values improve when an FSS-restrictive diet is followed; however, previous data on CDT and fructose intake correlation are inconsistent. Therefore, we examined the complete serum sialoTf profile and correlated it with FSS dietary intake and with hepatic parameters in a cohort of paediatric and adult fructosemic patients. To do so, the profiles of serum sialoTf from genetically diagnosed HFI patients on an FSS-restricted diet (
    Sprache Englisch
    Erscheinungsdatum 2021-06-30
    Erscheinungsland Switzerland
    Dokumenttyp Journal Article
    ZDB-ID 2662592-1
    ISSN 2077-0383
    ISSN 2077-0383
    DOI 10.3390/jcm10132932
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  7. Artikel ; Online: Intravenous supplementation type and volume are associated with 1-year outcome and major complications in patients with chronic intestinal failure.

    Pironi, Loris / Steiger, Ezra / Joly, Francisca / Wanten, Geert J A / Chambrier, Cecile / Aimasso, Umberto / Sasdelli, Anna Simona / Szczepanek, Kinga / Jukes, Amelia / Theilla, Miriam / Kunecki, Marek / Daniels, Joanne / Serlie, Mireille J / Cooper, Sheldon C / Poullenot, Florian / Rasmussen, Henrik Højgaard / Compher, Charlene W / Crivelli, Adriana / Hughes, Sarah-Jane /
    Santarpia, Lidia / Guglielmi, Francesco William / Rotovnik Kozjek, Nada / Ellegard, Lars / Schneider, Stéphane M / Matras, Przemysław / Forbes, Alastair / Wyer, Nicola / Zmarzly, Anna / Taus, Marina / O'Callaghan, Margie / Osland, Emma / Thibault, Ronan / Cuerda, Cristina / Jones, Lynn / Chapman, Brooke / Sahin, Peter / Virgili, Núria M / Lee, Andre Dong Won / Orlandoni, Paolo / Matysiak, Konrad / Di Caro, Simona / Doitchinova-Simeonova, Maryana / Masconale, Luisa / Spaggiari, Corrado / Garde, Carmen / Serralde-Zúñiga, Aurora E / Olveira, Gabriel / Krznaric, Zeljko / Petrina Jáuregui, Estrella / Zugasti Murillo, Ana / Suárez-Llanos, José P / Nardi, Elena / Van Gossum, André / Lal, Simon

    Gut

    2020  Band 69, Heft 10, Seite(n) 1787–1795

    Abstract: Background and aim: No marker to categorise the severity of chronic intestinal failure (CIF) has been developed. A 1-year international survey was carried out to investigate whether the European Society for Clinical Nutrition and Metabolism clinical ... ...

    Abstract Background and aim: No marker to categorise the severity of chronic intestinal failure (CIF) has been developed. A 1-year international survey was carried out to investigate whether the European Society for Clinical Nutrition and Metabolism clinical classification of CIF, based on the type and volume of the intravenous supplementation (IVS), could be an indicator of CIF severity.
    Methods: At baseline, participating home parenteral nutrition (HPN) centres enrolled all adults with ongoing CIF due to non-malignant disease; demographic data, body mass index, CIF mechanism, underlying disease, HPN duration and IVS category were recorded for each patient. The type of IVS was classified as fluid and electrolyte alone (FE) or parenteral nutrition admixture (PN). The mean daily IVS volume, calculated on a weekly basis, was categorised as <1, 1-2, 2-3 and >3 L/day. The severity of CIF was determined by patient outcome (still on HPN, weaned from HPN, deceased) and the occurrence of major HPN/CIF-related complications: intestinal failure-associated liver disease (IFALD), catheter-related venous thrombosis and catheter-related bloodstream infection (CRBSI).
    Results: Fifty-one HPN centres included 2194 patients. The analysis showed that both IVS type and volume were independently associated with the odds of weaning from HPN (significantly higher for PN <1 L/day than for FE and all PN >1 L/day), patients' death (lower for FE, p=0.079), presence of IFALD cholestasis/liver failure and occurrence of CRBSI (significantly higher for PN 2-3 and PN >3 L/day).
    Conclusions: The type and volume of IVS required by patients with CIF could be indicators to categorise the severity of CIF in both clinical practice and research protocols.
    Mesh-Begriff(e) Administration, Intravenous/methods ; Adult ; Catheter-Related Infections/complications ; Chronic Disease ; Drug Dosage Calculations ; Fat Emulsions, Intravenous/administration & dosage ; Female ; Fluid Therapy/methods ; Humans ; Intestinal Absorption ; Intestinal Diseases/etiology ; Intestinal Diseases/physiopathology ; Intestinal Diseases/therapy ; Intestines/physiopathology ; Liver Failure/complications ; Male ; Parenteral Nutrition, Home/adverse effects ; Parenteral Nutrition, Home/methods ; Pharmaceutical Solutions/administration & dosage ; Severity of Illness Index
    Chemische Substanzen Fat Emulsions, Intravenous ; Pharmaceutical Solutions
    Sprache Englisch
    Erscheinungsdatum 2020-01-21
    Erscheinungsland England
    Dokumenttyp Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 80128-8
    ISSN 1468-3288 ; 0017-5749
    ISSN (online) 1468-3288
    ISSN 0017-5749
    DOI 10.1136/gutjnl-2018-318172
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

Zum Seitenanfang